October 16, 2026
NIH grant supports research to improve CAR T cell therapies
Purdue researcher Shalini Low-Nam has received a five-year R01 grant from the National Institutes of Health (NIH) to investigate the molecular signals that control activation of chimeric antigen receptor (CAR) T cells, a type of engineered immune cell used in…
Read More